Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.84 EUR | +0.09% | -.--% | -.--% |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 8.77B | - | ||
+1.58% | 1.47B | D | ||
-9.91% | 1.33B | B+ | ||
-4.89% | 1.22B | - | ||
-26.95% | 766M | - | - | |
+1.67% | 459M | - | ||
+1.70% | 431M | - | - | |
-62.86% | 266M | - | ||
-32.42% | 299M | - | - | |
-0.08% | 218M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.